Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 182

1.

[Neuroendocrine differentiation in prostate cancer. An unrecognized and therapy-resistant phenotype].

Bonkhoff H, Fixemer T.

Urologe A. 2004 Jul;43(7):836-42. Review. German.

PMID:
15048555
2.
4.

The neuroendocrine phenotype in prostate cancer: basic and clinical aspects.

Mosca A, Berruti A, Russo L, Torta M, Dogliotti L.

J Endocrinol Invest. 2005;28(11 Suppl International):141-5. Review.

PMID:
16625864
5.

New perspective in the management of neuroendocrine differentiation in prostate adenocarcinoma.

Sciarra A, Cardi A, Dattilo C, Mariotti G, Di Monaco F, Di Silverio F.

Int J Clin Pract. 2006 Apr;60(4):462-70. Review.

PMID:
16620361
6.

Neuroendocrine-like prostate cancer cells: neuroendocrine transdifferentiation of prostate adenocarcinoma cells.

Yuan TC, Veeramani S, Lin MF.

Endocr Relat Cancer. 2007 Sep;14(3):531-47. Review.

7.

Evaluation and clinical value of neuroendocrine differentiation in human prostatic tumors.

Cussenot O, Villette JM, Cochand-Priollet B, Berthon P.

Prostate Suppl. 1998;8:43-51. Review.

PMID:
9690663
8.

[Morphogenesis of benign prostatic hyperplasia and prostatic carcinoma].

Bonkhoff H, Remberger K.

Pathologe. 1998 Jan;19(1):12-20. Review. German.

PMID:
9541938
9.

Neuroendocrine differentiation in the progression of prostate cancer.

Komiya A, Suzuki H, Imamoto T, Kamiya N, Nihei N, Naya Y, Ichikawa T, Fuse H.

Int J Urol. 2009 Jan;16(1):37-44. doi: 10.1111/j.1442-2042.2008.02175.x. Review.

10.
11.

Neuroendocrine differentiation in prostatic carcinoma.

Abrahamsson PA.

Prostate. 1999 May;39(2):135-48. Review.

PMID:
10221570
12.

Neuroendocrine cells in tumour growth of the prostate.

Abrahamsson PA.

Endocr Relat Cancer. 1999 Dec;6(4):503-19. Review.

13.

Somatostatin receptors: from basic science to clinical approach. Unlabeled somatostatin analogues-1: Prostate cancer.

Mosca A, Dogliotti L, Berruti A, Lamberts SW, Hofland LJ.

Dig Liver Dis. 2004 Feb;36 Suppl 1:S60-7. Review.

PMID:
15077913
15.

The biology of hormone refractory prostate cancer. Why does it develop?

Isaacs JT.

Urol Clin North Am. 1999 May;26(2):263-73. Review.

PMID:
10361549
16.

Endocrine treatment of prostate cancer.

Tammela T.

J Steroid Biochem Mol Biol. 2004 Nov;92(4):287-95. Epub 2004 Dec 31. Review.

PMID:
15663992
17.

Neuroendocrine cells in prostate cancer.

Amorino GP, Parsons SJ.

Crit Rev Eukaryot Gene Expr. 2004;14(4):287-300. Review.

PMID:
15663358
18.
19.
20.

Neuroendocrine differentiation in human prostatic carcinoma.

di Sant'Agnese PA.

Hum Pathol. 1992 Mar;23(3):287-96. Review.

PMID:
1313390

Supplemental Content

Support Center